Found: 56
Select item for more details and to access through your institution.
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study.
- Published in:
- BJU International, 2011, v. 107, n. 7, p. 1110, doi. 10.1111/j.1464-410X.2010.09687.x
- By:
- Publication type:
- Article
Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment.
- Published in:
- BJU International, 2010, v. 105, n. 4, p. 502, doi. 10.1111/j.1464-410X.2009.08822.x
- By:
- Publication type:
- Article
Postoperative Outcome of Patients Who Underwent Total Joint Replacement During the Tanezumab Phase 3 Osteoarthritis Development Program: A 24-Week Observational Study.
- Published in:
- Surgical Technology International, 2021, v. 38, p. 1
- By:
- Publication type:
- Article
The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis.
- Published in:
- World Journal of Men's Health, 2014, v. 32, n. 1, p. 28, doi. 10.5534/wjmh.2014.32.1.28
- By:
- Publication type:
- Article
Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo‐controlled trials.
- Published in:
- International Journal of Clinical Practice, 2021, v. 75, n. 12, p. 1, doi. 10.1111/ijcp.14975
- By:
- Publication type:
- Article
Multimodal Treatment Patterns for Osteoarthritis and Their Relationship to Patient-Reported Pain Severity: A Cross-Sectional Survey in the United States.
- Published in:
- Journal of Pain Research, 2020, v. 13, p. 3415, doi. 10.2147/JPR.S285124
- By:
- Publication type:
- Article
Nerve Growth Factor Signaling and Its Contribution to Pain.
- Published in:
- Journal of Pain Research, 2020, v. 13, p. 1223, doi. 10.2147/JPR.S247472
- By:
- Publication type:
- Article
Clinical practice guidelines on the initial assessment and treatment of urinary incontinence in women: a US focused review
- Published in:
- International Journal of Gynecology & Obstetrics, 2004, v. 86, p. S25, doi. 10.1016/j.ijgo.2004.05.008
- By:
- Publication type:
- Article
Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
- Published in:
- BMC Urology, 2012, v. 12, n. 1, p. 30, doi. 10.1186/1471-2490-12-30
- By:
- Publication type:
- Article
Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial.
- Published in:
- BMC Urology, 2008, v. 8, p. 1, doi. 10.1186/1471-2490-8-2
- By:
- Publication type:
- Article
Factors associated with physician-reported treatment status of patients with osteoarthritis pain.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The handling of urinary incontinence in Danish general practices after distribution of guidelines and voiding diary reimbursement: an observational study.
- Published in:
- BMC Family Practice, 2004, v. 5, p. 13, doi. 10.1186/1471-2296-5-13
- By:
- Publication type:
- Article
Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness Survey.
- Published in:
- World Journal of Urology, 2015, v. 33, n. 5, p. 639, doi. 10.1007/s00345-014-1366-6
- By:
- Publication type:
- Article
Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies.
- Published in:
- World Journal of Urology, 2014, v. 32, n. 5, p. 1127, doi. 10.1007/s00345-014-1255-z
- By:
- Publication type:
- Article
Opioids for Osteoarthritis: Cross-Sectional Survey of Patient Perspectives and Satisfaction.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 7, p. 2733, doi. 10.3390/jcm12072733
- By:
- Publication type:
- Article
Opioid Prescribing for Osteoarthritis: Cross-Sectional Survey among Primary Care Physicians, Rheumatologists, and Orthopaedic Surgeons.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 2, p. 589, doi. 10.3390/jcm12020589
- By:
- Publication type:
- Article
Burden of chronic low back pain: Association with pain severity and prescription medication use in five large European countries.
- Published in:
- Pain Practice, 2022, v. 22, n. 3, p. 359, doi. 10.1111/papr.13093
- By:
- Publication type:
- Article
Pharmacotherapy for Stress Urinary Incontinence: Present and Future Options.
- Published in:
- Drugs, 2004, v. 64, n. 14, p. 1503, doi. 10.2165/00003495-200464140-00001
- By:
- Publication type:
- Article
Reliability of Wearable Sensors for Assessing Gait and Chair Stand Function at Home in People With Knee Osteoarthritis.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 9, p. 1939, doi. 10.1002/acr.25096
- By:
- Publication type:
- Article
General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 6, p. 918, doi. 10.1002/acr.24637
- By:
- Publication type:
- Article
WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Do fertile women remember the onset of stress incontinence? Recall bias 5 years after 1st delivery.
- Published in:
- 2001
- By:
- Publication type:
- journal article
The not so hidden impact of interictal burden in migraine: A narrative review.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 01, doi. 10.3389/fneur.2022.1032103
- By:
- Publication type:
- Article
Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of action.
- Published in:
- Therapeutic Advances in Urology, 2015, v. 7, n. 5, p. 249, doi. 10.1177/1756287215589238
- By:
- Publication type:
- Article
Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 4, p. 878, doi. 10.1002/cpt.2842
- By:
- Publication type:
- Article
Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis.
- Published in:
- Advances in Rheumatology, 2024, v. 64, n. 1, p. 1, doi. 10.1186/s42358-024-00358-y
- By:
- Publication type:
- Article
Efficacy and safety of tadalafil 5 mg once‐daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double‐blind, parallel, placebo‐ and tamsulosin‐controlled study
- Published in:
- International Journal of Urology, 2019, v. 26, n. 2, p. 192, doi. 10.1111/iju.13828
- By:
- Publication type:
- Article
Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placebo
- Published in:
- International Journal of Urology, 2015, v. 22, n. 6, p. 582, doi. 10.1111/iju.12741
- By:
- Publication type:
- Article
Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies.
- Published in:
- International Journal of Urology, 2015, v. 22, n. 4, p. 378, doi. 10.1111/iju.12699
- By:
- Publication type:
- Article
Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea.
- Published in:
- International Journal of Urology, 2014, v. 21, n. 7, p. 670, doi. 10.1111/iju.12410
- By:
- Publication type:
- Article
Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
- Published in:
- International Journal of Urology, 2013, v. 20, n. 2, p. 193, doi. 10.1111/j.1442-2042.2012.03130.x
- By:
- Publication type:
- Article
Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo-controlled clinical studies
- Published in:
- BJU International, 2017, v. 119, n. 5, p. 793, doi. 10.1111/bju.13744
- By:
- Publication type:
- Article
Proportion of tadalafil-treated patients with clinically meaningful improvement in lower urinary tract symptoms associated with benign prostatic hyperplasia - integrated data from 1 499 study participants.
- Published in:
- BJU International, 2015, v. 115, n. 5, p. 815, doi. 10.1111/bju.12926
- By:
- Publication type:
- Article
Tadalafil once daily in the treatment of lower urinary tract symptoms ( LUTS) suggestive of benign prostatic hyperplasia ( BPH) in men without erectile dysfunction.
- Published in:
- BJU International, 2013, v. 112, n. 7, p. 990, doi. 10.1111/bju.12251
- By:
- Publication type:
- Article
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 7, p. 551, doi. 10.1007/s40261-023-01286-3
- By:
- Publication type:
- Article
Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A 3‐year follow‐up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims‐based cohort study in the United States.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 7, p. 796, doi. 10.1111/head.14741
- By:
- Publication type:
- Article
Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies.
- Published in:
- Health & Quality of Life Outcomes, 2010, v. 8, p. 131, doi. 10.1186/1477-7525-8-131
- By:
- Publication type:
- Article
Long‐Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 7, p. 1167, doi. 10.1002/art.41674
- By:
- Publication type:
- Article
Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis”.
- Published in:
- Journal of Anaesthesiology Clinical Pharmacology, 2018, v. 34, n. 4, p. 548, doi. 10.4103/joacp.JOACP_155_18
- By:
- Publication type:
- Article
Office assessment of urinary incontinence.
- Published in:
- Contemporary OB/GYN, 2004, v. 49, n. 10, p. 42
- By:
- Publication type:
- Article
A Randomized Placebo-Controlled Trial of the Anti-Nerve Growth Factor Antibody Tanezumab in Subjects With Cancer Pain Due to Bone Metastasis.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1268, doi. 10.1093/oncolo/oyad188
- By:
- Publication type:
- Article
Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 4, p. 1759, doi. 10.1007/s40744-021-00372-2
- By:
- Publication type:
- Article
Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 Trial.
- Published in:
- Pain & Therapy, 2022, v. 11, n. 4, p. 1267, doi. 10.1007/s40122-022-00424-7
- By:
- Publication type:
- Article
Satisfaction with Medications Prescribed for Osteoarthritis: A Cross-Sectional Survey of Patients and Their Physicians in the United States.
- Published in:
- Pain & Therapy, 2022, v. 11, n. 1, p. 191, doi. 10.1007/s40122-021-00350-0
- By:
- Publication type:
- Article
Characterizing 16-Week Responder Profiles Using Group-Based Trajectory Modeling in Over 4300 Clinical Trial Participants Receiving Pharmaceutical Treatment for Moderate to Severe Osteoarthritis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Urinary incontinence during pregnancy and 1 year after delivery in primiparous women compared with a control group of nulliparous women.
- Published in:
- Neurourology & Urodynamics, 2012, v. 31, n. 4, p. 475, doi. 10.1002/nau.21221
- By:
- Publication type:
- Article
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action.
- Published in:
- Neurourology & Urodynamics, 2011, v. 30, n. 3, p. 292, doi. 10.1002/nau.20999
- By:
- Publication type:
- Article
Reductions in stress urinary incontinence episodes: What is clinically important for Women?
- Published in:
- Neurourology & Urodynamics, 2010, v. 29, n. 3, p. 344, doi. 10.1002/nau.20744
- By:
- Publication type:
- Article